rac-3-(3-(4-(4-Trifluoromethylbenzyl)piperazin-1-yl)propyl)isobenzofuran-1(3H)-one

ID: ALA5181502

Chembl Id: CHEMBL5181502

PubChem CID: 141736874

Max Phase: Preclinical

Molecular Formula: C23H25F3N2O2

Molecular Weight: 418.46

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1OC(CCCN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c2ccccc21

Standard InChI:  InChI=1S/C23H25F3N2O2/c24-23(25,26)18-9-7-17(8-10-18)16-28-14-12-27(13-15-28)11-3-6-21-19-4-1-2-5-20(19)22(29)30-21/h1-2,4-5,7-10,21H,3,6,11-16H2

Standard InChI Key:  JJUSXWIHZMANLG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5181502

    ---

Associated Targets(Human)

GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2A (719 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2B (726 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Ionotropic glutamate receptor NMDA 1/2C (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Ionotropic glutamate receptor NMDA 1/2D (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grin1 Glutamate NMDA receptor (6467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 418.46Molecular Weight (Monoisotopic): 418.1868AlogP: 4.51#Rotatable Bonds: 6
Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 13.88CX Basic pKa: 8.07CX LogP: 4.63CX LogD: 3.88
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -0.57

References

1. Xu Q, Hu M, Li J, Ma X, Chu Z, Zhu Q, Zhang Y, Zhu P, Huang Y, He G..  (2022)  Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.,  227  [PMID:34710748] [10.1016/j.ejmech.2021.113876]
2. Xu Q, Hu M, Li J, Ma X, Chu Z, Zhu Q, Zhang Y, Zhu P, Huang Y, He G..  (2022)  Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.,  227  [PMID:34710748] [10.1016/j.ejmech.2021.113876]
3. Xu Q, Hu M, Li J, Ma X, Chu Z, Zhu Q, Zhang Y, Zhu P, Huang Y, He G..  (2022)  Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.,  227  [PMID:34710748] [10.1016/j.ejmech.2021.113876]

Source